Cargando…
Mucins as Potential Biomarkers for Early Detection of Cancer
SIMPLE SUMMARY: Early cancer detection is a challenge in treating cancer patients. Remarkably, carcinomas of the breast, lung, liver, pancreas, ovary, and colon contribute to more than 50% of total incidences and mortality annually, which could be reduced by early detection. As mucins are highly upr...
Autores principales: | Gautam, Shailendra K., Khan, Parvez, Natarajan, Gopalakrishnan, Atri, Pranita, Aithal, Abhijit, Ganti, Apar K., Batra, Surinder K., Nasser, Mohd W., Jain, Maneesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046558/ https://www.ncbi.nlm.nih.gov/pubmed/36980526 http://dx.doi.org/10.3390/cancers15061640 |
Ejemplares similares
-
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
por: Shah, Ashu, et al.
Publicado: (2023) -
RNA-based therapies: A cog in the wheel of lung cancer defense
por: Khan, Parvez, et al.
Publicado: (2021) -
Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β)
por: Kshirsagar, Prakash G., et al.
Publicado: (2021) -
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
por: Gautam, Shailendra K., et al.
Publicado: (2023) -
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
por: Gautam, Shailendra K., et al.
Publicado: (2020)